Abaxis Stock Analysis (NASDAQ:ABAX)
Abaxis Analysis Video
View Abaxis stock analysis video. This is our ABAX analyst opinion covering the buy and sell arguments for ABAX stock.
Abaxis Inc Stock Rating (3.7/5)
Our Abaxis stock opinion is based on fundamentals of the company. This Abaxis stock analysis is based on latest Q2 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.
Should you buy ABAX stock?
- Abaxis's average operating margin of 20.4% was exceptional.
- Net margins came in at average 15.5% for Abaxis over the last twelve months.
- With a debt/equity ratio of 0, Abaxis is comparatively less leveraged than its peers in the Medical sector.
- Abaxis has an attractive ROIC (Return on Invested Capital) of 27.9%
- Abaxis has a good Return On Equity (ROE) of 14.6%.
Should you sell ABAX stock?
- Cash flow from operations is low at 0.5 times the net income.
- ABAX stock is trading at a PE ratio of 36.4, which is worse than the industry average multiple of 22.1.